Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 3,474 shares at $135.06 ($469K) on 2017-10-02, disclosed to the SEC on 2017-10-03.
Seasonal sale ($469k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.06 | 1,737 | $235K | 50.0% |
| 2 | $135.06 | 1,737 | $235K | 50.0% |
| Total | $135.06 avg | 3,474 | $469K | 100% |
| Filing → |
| ACN | SELL | 2017-12-27 | $573K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |
| ACN | SELL | 2017-04-28 | $329K | — | Filing → |